Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives

Eitemau Tebyg

• Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
  gan: Shi, Ming-Jun, et al.
  Cyhoeddwyd: (2020)
• The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution
  gan: Mégnin-Chanet, Frédérique, et al.
  Cyhoeddwyd: (2002)
• IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
  gan: Neuzillet, Yann, et al.
  Cyhoeddwyd: (2017)
• Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
  gan: Lebret, Thierry, et al.
  Cyhoeddwyd: (2015)
• TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
  gan: Dufour, Florent, et al.
  Cyhoeddwyd: (2019)